Table 3.
Hybrid Hydrogel Composite | Obtainment Method | Properties | Application | Reference |
---|---|---|---|---|
Alginate-based hybrid hydrogels | ||||
PVA/alginate (Alg) | Physical crosslinking of PVA, followed by chemical crosslinking with alginate | * highly porous, open-cellular pore structures * pore size very 290–190 μm, depending on PVA concentration * scaffolds softer and more elastic than the control alginate, without affecting the mechanical strength * better cell adhesion and faster growth than the control alginate |
Scaffolds for cartilage tissue engineering | [196] |
PVA/SA hydrogel, containing nitrofurazone | FT method | * increase of SA concentration in PVA hydrogel films increased the swelling ability, elasticity, and thermal stability of PVA/SA hydrogel system * increase of SA content led to significant decreases in gel fraction %, and mechanical properties of PVA/SA hydrogel * low SA content resulted in a decreased protein adsorption, indicating a better blood compatibility |
Wound dressing | [197] |
Biodegradable PVA/SA-clindamycin-loaded hydrogel film | Physical crosslinking conducted by the FT method |
* increasing SA concentration decreased the gelation (%), maximum strength and break elongation, but it resulted in an increase in the swelling ability, elasticity and thermal stability of the hydrogel film * SA content had an insignificant effect on the release profile of clindamycin from the PVA/SA film, whereas PVA/SA-clindamycin improved the healing rate of artificial wound in rats |
Wound dressing |
[198] |
PVA/Alg (1/1 weight ratio) nanofiber hydrogels | In situ crosslinking using citric acid (5 wt%) + curing at 140 °C, for 2 h + conditioning at room temperature | * enhanced thermal stability and insolubility in both water and simulated body fluid (SBF) for 2 days | Tissue engineering | [199] |
PVA/calcium alginate nanofiber web | Electrospinning technique | * a maximum calcium alginate content showed the maximum water vapor transmission rate that help in maintaining the local moist environment for accelerating wound healing * apparently new epithelium formation without any harmful reactions, when the wound is covered with the PVA based nanofiber |
Wound healing | [200] |
PVA/Alg reinforced with cellulose nanocrystals (CNCs) | Acidic hydrolysis | * fibrous porous structure (95.2% porosity) and improved mechanical stability * good properties for in vitro cell attachment |
Scaffolds with good proliferation for fibroblast cells | [201,202] |
Chondroitin sulfate-based hybrid hydrogels | ||||
Chondroitin sulfate (CTS)/PEG | FXIIIa-mediated crosslinking of chondroitin sulfate grafted with PEG | * tuned growth factor binding and release * promoting of stem cell proliferation and osteogenic differentiation |
Treatment of osteogenesis | [203] |
PVA/HA/CTS hydrogels | Gamma irradiation (5–25 kGy) | * hydrogels with a higher content of HA/CTS exhibited higher enzymatic degradation rates * PVA/HA/CTS hydrogels cultures with human keratinocytes (HaCaT) showed higher cell viability (more than 90%), when compared to the control sample |
Potential application in skin tissue engineering | [204] |
Glucan-based hybrid hydrogels | ||||
PVA/glucan films | Physical blending, followed by drying at 110 °C, without using chemically crosslinking | * no covalent bond between PVA and glucan was found in the formed film; glucan can be released to facilitate wound healing * an increase in glucan content led to a decrease in the tensile strength and an increase of the breaking elongation * a high glucan content with PVA film can hinder the cell mobility and prolong the time of healing * healing time of wound can be shortened by 48%, when glucan content is optimized |
Wound dressing | [205] |
Chitosan (CS) and chitosan derivatives-based hydrogels | ||||
PVA/CS hydrogels | Crosslinking induced by exposure to different doses of γ-radiation | * gel fraction and mechanical properties of the hydrogels increased with increasing PVA concentration and irradiation dose * swelling ability of the hydrogels increased with increasing the CS content |
Prevention of microbiological growth, such as bacteria, fungi and microorganisms, with possible use as wound dressing material | [206] |
PVA/CS hydrogel membranes | FTcycle, followed by γ-irradiation process | * larger swelling capacity, high mechanical strength, lower water evaporation, and high thermal stability were obtained * good antibacterial activity against Escherichia coli with increasing CS content |
Wound dressing | [207] |
Addition of glycerol into PVA/CS hydrogels | Irradiation followed by FT | * acceleration of the healing process of wounds in a rat model * nontoxicity toward L929 mouse fibroblast cells * mature epidermal architecture was formed after the 11th day postoperatively |
Wound dressing | [208] |
Temperature-sensitive CS/PVA hydrogel | Chemical crosslinking, using glutaraldehyde | * the release of paclitaxel (PTX) in PBS (pH 7.4) is sustainable for 13 days * the antitumor activity of the drug-loaded composite hydrogel is 3.7 fold higher than that of Taxol |
Intratumoral delivery of PTX | [209] |
PVA/CS hydrogel loaded with vitamin B12 | Physical blending between different portions of PVA and water soluble CS, followed by treatment with formaldehyde to convert –NH2 group of CS into -N=C group in PVA/CS membranes |
* increasing of CS content increases water content, water vapor transmission, and permeability of loaded vitamin B12 through PVA/CS membranes | Potential biomedical applications | [210] |
Minocycline loaded PVA/CS hydrogel films | FT method | * high CS concentrations decreased gel fraction, mechanical properties, and thermal stability, and it increased the swelling ability, water vapor transmission, elasticity, and porosity of PVA/CS hydrogel films * faster healing of the wound when compared to the conventional sterile gauze control |
Wound dressing | [211] |
Nano-insulin loaded CS/PVA hydrogel | Chemical crosslinking, using glutaraldehyde as the cross-linking agent | * miscibility of nano-insulin and hydrogel * porous structure, with good deformability and flexibility * constant release of the insulin * high permeation rate of nano-insulin |
Transdermal insulin delivery | [212] |
CS / PVA nanofiber mats | Electrospinning, using different CS salts (CS-hydroxybenzotriazole (HOBt), CS-ethylenediaminetetraacetic acid (EDTA), and CS-thiamin pyrophosphate (TPP)) | * increase of the swelling degree with increasing CS; concentration, whatever the CS salt * no toxic compounds that reduce the cellular growth of fibroblasts * highest antibacterial activity and better healing activity were obtained for CS-EDTA/PVA fiber |
Wound healing system | [213] |
PVA/CS/gelatin hydrogel, incorporating polycaprolactone microspheres |
Physically incorporation | * improvement of the mechanical properties by PVA * improvement of cell adhesion by gelatin |
Delivery of basic fibroblast growth factor (bFGF) |
[214] |
CS/gelatin/PVA hydrogels | Gamma-irradiation | * increase of the swelling capacity with increasing the CS/gelatin ratio * 3D network structure with a good evaporation rate * about 10–20% water retained in 24 h; * good coagulation effect |
Wound dressing | [215] |
Gelatin/CS/PVA/ Arabic gum nanofibers |
Electrospinning | * steady permeability of large molecules (e.g., BSA) * excellent cell attachment and proliferation |
Wound healing | [216] |
Gelatin/CS/PVA hydrogels | FT process | * non-toxic for the HT29-MTX-E12 cell line | Potential for tissue engineering applications | [217] |
CS/polyethylenimine (PEI) 3D hydrogels | Physical mixture | * stable under cell culture conditions * could support the growth of primary human fetal skeletal cells |
Gene transfection agent | [218] |
CS-PEG co-polymer (CS-g-PEG) | Chemically grafting of monohydroxy PEG onto the CS backbone, using Schiff base and sodium cyanoborohydride chemistry | * obtainment of an injectable, thermoreversible gel * by optimizing PEG content (45–55 wt.%) and PEG molecular weight, the resultant system underwent a thermoreversible transition from an injectable solution at room temperature to a gel at body temperature |
Potential carrier matrices for a wide range of biomedical and pharmaceutical applications |
[219] |
Thermo-responsive PEG-grafted CS hydrogel | Physical crosslinking | * steady protein release pattern for a period of 70 h after an initial burst release in the first 5 h * by crosslinking with genipin, it was obtained a prolonged quasi-linear release of the protein for up to 40 days; the initial burst release was reduced |
Sustained BSA release | [220] |
Injectable composite scaffold obtained from collagen-coated polylactide micro carriers/CS hydrogel | Physical crosslinking | * collagen-coated polylactide micro carriers enhanced the mechanical properties * cell metabolic activity increased before 9 days of in vitro chondrocytes growth within the scaffold * after 9–12 days, confluent cell layers were formed |
Tissue engineering applications, particularly in orthopedics |
[221] |
CS/Poly(ε-caprolactone) (PCL)/polypyrrole | Electrospun | enhanced attachment and proliferation of PC12 cells | Neural tissue substrate | [222] |
Maleiated CS/thiol-terminated PVA | Solvent casting | fetal porcine hepatocytes survived at least 14 days | Hepatocyte attachment | [223] |
PVA/carboxymethyl chitosan (CM)-chitosan hydrogels | Electron beam rosslinking at room temperature | * mechanical properties and swelling degree improved after adding CM-chitosan * considerable antibacterial activity against E. coli for a low CM-chitosan content |
Antibacterial activity | [224] |
PVA/CM/honey | FT method | * inhibition of the growth of Escherichia coli bacteria * presence of honey leads to faster wound healing |
Wound dressing | [225] |
Carboxyethyl chitosan (CE)/PVA nanofiber mats | Electrospinning of aqueous CE-chitosan/PVA solution |
* CE-chitosan/PVA nanofiber mat was nontoxic to the L929 cells * good in promoting the L929 cell attachment and proliferation |
Skin regeneration and healing | [226] |
PVA/quaternary chitosan (Q-chitosan mats | Photo-crosslinking electrospinning technique |
* efficient inhibition toward growth of Gram-positive and Gram-negative bacteria | Wound dressing applications | [227] |
Q-chitosan/polyaniline/ oxidized dextran (DEX) |
Lyophilization | High antibacterial activity and enhanced proliferation of C2C12 myoblasts | In situ forming antibacterial and electroactive hydrogels | [228] |
Quaternary ammonium chitosan/PVA hydrogels | Gamma irradiation, at different radiation doses and for different polymer ratios | * very good swelling ability (1000–4000%), water evaporation rate and mechanical properties * for doses <40 kGy, the tensile strength increases with increasing the radiation dose * higher crosslinking degree of the hydrogel with increasing the radiation dose * for doses >40 kGy, the hydrogel degraded * inhibition of the growth of Staphylococcus aureus and Escherichia coli |
Antimicrobial system | [229] |
Poly-4-styrenesulfonic acid/methacrylated glycol CS (MeGC) hydrogel or poly-vinylsulfonic acid/MeGC | Photo-crosslinking | * the initial burst was decreased after adding PSS or PVSA * higher human bone morphogenetic protein-2 (BMP-2)-induced osteogenesis differentiation |
Efficient protein delivery | [230] |
pH and temperature dual-sensitive hydrogel between glycol chitosan and benzaldehyde-modified Pluronic |
Schiff base reaction | in physiological conditions, it was obtained the release of doxorubicin (DOX) and prednisolone from the hydrogels, without any initial burst release | Drug delivery system | [231] |
Thermo-responsive Pluronic grafted CS hydrogel | Grafting of Pluronic onto chitosan using EDC/NHS chemistry | * higher mechanical properties than Pluronic hydrogels * in vitro culture of bovine chondrocytes in the hydrogel showed that the cell number and synthesized glycosaminoglycan (GAG) increased spontaneously over a period of 28 days |
Cartilage regeneration | [232] |
CS-Pluronic nano-hydrogel with targeting peptides | Photo-crosslinking | * high accumulation efficiency in brain tissues |
Delivery of β-galactosidase to brain | [233] |
CS-Pluronic hydrogels with encapsulated recombinant human epidermal growth factor (rhEGF) |
Photo-croslinking | * the release of rhEGF is highly related to the degradation rate of the hydrogels * difference in rhEGF release patterns within 1 day, for different photoirradiation time (2 min–5 min) * epidermal differentiation is highly enhanced * good muco-adhesive property with animal skins |
Wound curing | [234] |
Semi-interpenetrating polymer network CS/ PEG/acrylamide (AAm) hydrogels | Chemical crosslinking | * increase of the protein half-life * improvement of the CS biocompatibility * increasing PEG content increased the swelling ratio, protein loading capacity, and entrapment efficiency |
Closed-loop insulin delivery | [235] |
Methacrylate derivative of CS/poly(ethylene oxide diacrylate) (PEODA) | Photo-crosslinking (intensity of UV light ≈ 10 mW/cm2, at a wavelength of 365 nm) | * good mechanical strength * degradation of the gels in the presence of chondroitinase enzyme in a dose-response manner * no degradation in the absence of the enzyme * compatibility with chondrocytes |
Cartilage tissue engineering | [236] |
Hyaluronic acid-based hybrid hydrogels | ||||
Maleiated HA/thiol-terminated PEG | Mould-casting | quick gelation, porous structures, tunable degradation, and cytocompatibility with L929 cells | In situ formed scaffolds for tissue engineering | [237] |
HA/PEG-diacrylate coencapsulated with TGF-β-3 | Photo-crosslinking | Cartilage differentiation | Cartilage tissue engineering | [238] |
Injectable hydrogels of thiolated HA and 4-arm PEG-vinyl sulfone | Michael-type addition reaction | * gelation time decreased with the increase in the molecular weight (45–185 kDa) of HA * degradation time increased (15 days) with the molecular weight of HA and its degree of substitution * degradation in the presence of chondrocytes increased after 14 and 21 days, maybe due to the production of hyaluronidase enzyme by the incorporated chondrocytes |
Cartilage tissue engineering | [79] |
Methacrylated HA/N-vinyl pyrrolidone, using Alg as a temporal spherical mold | Photo-polymerization (long wavelength UV, 7W/cm2—intensity) | * degradable in the presence of hyaluronidase enzyme | Cartilage tissue engineering | [239] |
Hybrid injectable hydrogel, consisting of deferoxamine-loaded poly(lactic-co-glycolic acid) nanoparticles (NPs) incorporated into a HA/CS hydrogel |
Physical crosslinking | * angiogenesis was induced by deferoxamine drug release, but also by the presence of HA/CS hydrogel * cytocompatibility and cell proliferation * maximal blood vessels formation * beneficial effect of deferoxamine for neovascularization after 28 days when compared to HA/CS hydrogel |
Suitable support for microvascular extension |
[240] |
Hydrogels of HA with thermosensitive poly(N-isopropyl acrylamide-co-acrylic acid), incorporated with dexamethasone and growth factor TGF β-3 |
Temperature-induced crosslinking | * enhancement of chondrogenic differentiation and expression of aggregan, collagen type I and type II | Injectable tissue engineering construct for cartilage repair | [241] |
Xanthan gum-based hybrid hydrogels | ||||
PVA and xanthan gum (XG), in different molar ratios | Crosslinking, using trisodium trimetaphosphate | * for a molar ratio of 4:1 between PVA and XG, mechanical, swelling, and thermal properties superimposed with those of human nucleus pulposus (HNP) tissue * the hydrogels did not show any signs of cytotoxicity towards mouse fibroblasts (NIH3T3) |
Good candidate as a potential HNP substitute | [242] |
Hybrid (chitosan-g-glycidyl methacrylate) (CS–g–GMA)/xanthan hydrogel | Dissolved CS-g-GMA was mixed with the xanthan solution, under nitrogen gas flow, while keeping the temperature at 50 ± 1 °C under constant magnetic agitation |
viability of fibroblasts when cultured onto the synthesized hydrogels | Potential for use in biomedical engineering applications | [243] |
Heparin based hybrid hydrogels | ||||
Hep/PEG hybrid gels | UV-initiated thiolene reaction between thiolated Hep and diacrylated poly(ethylene) glycol (PEG-DA) | * hepatocyte growth factor (HGF) was retained after 5 days in the hybrid Hep/PEG hydrogel microstructures, but was rapidly released from pure PEG gel microstructures * hepatocytes residing next to Hep/PEG hydrogels were producing ∼4 times more albumin at day 7, compared to cells cultured next to inert PEG hydrogels |
* Designing cellular microenvironment in vitro * Vehicles for cell transplantation in vivo |
[244] |
Hep-based hydrogel system, formed by thiolated heparin and diacrylated PEG | Michael-type addition reaction | * encapsulation by the Hep -based hydrogel did not affect the chondrocyte viability (better than calcium-induced alginate gel) * hydrogel promoted chondrocyte proliferation, while maintaining chondrogenic nature |
Promising material for chondrocyte culture, potentially applicable for cartilage regeneration | [245] |
Hep/acrylated PEG hydrogel, with rat hepatocytes entrapped | Michael-type addition reaction | * the hydrogel was non-cytotoxic to cells, and promoted the hepatic function * hepatocytes entrapped in the Hep-based hydrogel maintained high levels of albumin and urea synthesis after three weeks in culture * hepatocyte growth factor (HGF) incorporated in the hydrogel was released in a controlled manner (only 40% of GF molecules released after 30 days in culture) |
Good characteristics for matrices for in vitro differentiation of hepatocytes or stem cells and as vehicles for transplantation of these cells |
[246] |
Hep-based hydrogel sheet containing thiolated Hep and diacrylated PEG | Photo polymerization |
* in vitro sustained release profile of human epidermal growth factor (hEGF) loaded in the hydrogel * acceleration of the wound healing after application of the hydrogels * advanced granulation tissue formation, capillary formation, and epithelialization in wounds treated by hEGF loaded Hep-based hydrogel |
Wound healing | [247] |
Hep-poloxamer/decellular spinal cord extracellular matrix (dscECM), used for fibroblast growth factor-2 (FGF2) attachment | EDC/NHS method | * treatment with FGF2-dscECM-HP hydrogel induced the recovery of the neuron functions and tissue morphology in rats that suffered from spinal cord injury (SCI) | Delivery of macromolecular proteins | [248] |